BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17726861)

  • 1. [Gastrointestinal stromal tumors (GIST)].
    Galbfach PJ; Langner EB; Czapiński-Tuzikiewicz T; Sroda A; Spychalski MI; Dziki AJ
    Wiad Lek; 2007; 60(3-4):114-9. PubMed ID: 17726861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New orientations in the management of advanced, metastatic gastrointestinal stromal tumors (GIST): combination of surgery and systemic therapy with imatinib in a case of primary gastric location].
    Catani M; De Milito R; Simi M
    Chir Ital; 2005; 57(1):127-33. PubMed ID: 15832750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
    Herawi M; Montgomery EA; Epstein JI
    Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal stromal tumor (GIST)--medical rarities?].
    Predescu D; Gheorghe M; Predoiu I; Iosif C; Constantin A; Chiru F; Cociu L; Constantinoiu S
    Chirurgia (Bucur); 2010; 105(4):577-85. PubMed ID: 20941986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful resection of an advanced gastrointestinal stromal tumor by neoadjuvant chemotherapy with imatinib- a case report].
    Nakajima S; Sonoda K; Kadokawa Y; Kawabe A; Yamamoto T
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2645-8. PubMed ID: 20009472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.
    Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP
    Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrointestinal stromal tumour: our experience].
    Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
    Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 60 cases with malignant gastrointestinal stromal tumors].
    Lin F; Cao J; Xia JT; Huang CM; DU H; Chen GQ; Wen MJ; Dai LH; Lai YY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):409-11. PubMed ID: 17043962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric GISTs. Personal experience.
    Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S
    Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of gastrointestinal stromal tumor (GIST) of the stomach and a consideration of its malignancy potential and treatment strategy - report of two cases].
    Asakage N; Kobayashi S; Gotou T; Sasaki M; Tsukada K; Suzuki T; Yamamoto T; Sekine M; Miyazaki E; Hirai S; Yamasaki S
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):919-23. PubMed ID: 17565257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neo-adjuvant treatment in gastrointestinal stromal tumor.
    Catania V; Consoli A; Cavallaro A; Liardo RL; Malaguarnera M
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):727-30. PubMed ID: 20707293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior rectal wall gastrointestinal stromal tumor presenting clinically as prostatic mass.
    Madden JF; Burchette JL; Raj GV; Daly JT; Tannenbaum M
    Urol Oncol; 2005; 23(4):268-72. PubMed ID: 16018942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
    Zhu J; Wang Y; Hou M; Li HY; Zhang J
    Oncology; 2007; 73(5-6):324-7. PubMed ID: 18497504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of gastrointestinal stromal tumor (GIST)--review of the literature and a case report].
    Geraci G; Li Volsi F; Pisello F; Sciumè C; Cajozzo M; Cavaleri C; Modica G
    Ann Ital Chir; 2005; 76(4):377-80; discussion 381. PubMed ID: 16550875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.